SELLAS Life Sciences (SLS) Receivables (2022)
SELLAS Life Sciences (SLS) has disclosed Receivables for 3 consecutive years, with $1.0 million as the latest value for Q1 2022.
- On a quarterly basis, Receivables changed N/A to $1.0 million in Q1 2022 year-over-year; TTM through Mar 2022 was $1.0 million, a N/A change, with the full-year FY2012 number at $250000.0, changed N/A from a year prior.
- Receivables was $1.0 million for Q1 2022 at SELLAS Life Sciences, down from $1.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $1.0 million in Q1 2022 to a low of $1.0 million in Q1 2022.